BG Medicine, Inc. has reported that net loss for the fourth quarter ended December 31, 2013 was $1.93 million, or $0.06 loss per share, compared to a net loss of $2.9 million, or $0.14 loss per share, for the same quarter ended December 31, 2012. Total revenues for the fourth quarter ended December 31, 2013 were $1.15 million, compared to $1.07 million for the same quarter ended December 31, 2012.

Net loss for the year ended December 31, 2013 was $15.85 million, or $0.58 loss per share, compared to a net loss of $23.77 million, or $1.18 loss per share, for the year ended December 31, 2012. Total revenues for the year ended December 31, 2013 were $4.07 million, compared to $2.81 million for the year ended December 31, 2012.